These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7613247)

  • 1. Magnetic resonance imaging of siderotic hepatic adenoma.
    Cheng YF; Huang CC; Weng HH; Lee TY
    J Formos Med Assoc; 1995 Mar; 94(3):138-40. PubMed ID: 7613247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic adenoma: MR characteristics and correlation with pathologic findings.
    Paulson EK; McClellan JS; Washington K; Spritzer CE; Meyers WC; Baker ME
    AJR Am J Roentgenol; 1994 Jul; 163(1):113-6. PubMed ID: 8010195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrolamellar hepatocellular carcinoma--an atypical MR manifestation.
    Hui MS; Choi WM; Perng HL; Chen LK; Yang KC; Chen TJ
    Hepatogastroenterology; 1998; 45(20):514-7. PubMed ID: 9638440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance susceptibility-weighted imaging versus other imaging modalities in detecting splenic siderotic lesions.
    Li C; Zhou D; Zhao J; Wang X; Mu W; Wang J
    PLoS One; 2013; 8(9):e73626. PubMed ID: 24040004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR characterization of focal liver lesions: pearls and pitfalls.
    Siegelman ES; Chauhan A
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):295-313. PubMed ID: 25086931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypointense liver lesion on T2-weighted MR images and what it means.
    Curvo-Semedo L; Brito JB; Seco MF; Costa JF; Marques CB; Caseiro-Alves F
    Radiographics; 2010 Jan; 30(1):e38. PubMed ID: 19901085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of liver cell adenoma: CT and MR imaging.
    Kawakatsu M; Vilgrain V; Erlinger S; Nahum H
    Abdom Imaging; 1997; 22(3):274-6. PubMed ID: 9107649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic adenomas: imaging and pathologic findings.
    Grazioli L; Federle MP; Brancatelli G; Ichikawa T; Olivetti L; Blachar A
    Radiographics; 2001; 21(4):877-92; discussion 892-4. PubMed ID: 11452062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images.
    Mitchell DG; Rubin R; Siegelman ES; Burk DL; Rifkin MD
    Radiology; 1991 Jan; 178(1):101-3. PubMed ID: 1845784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular papillary endothelial hyperplasia: magnetic resonance imaging of finger lesions.
    Sung J; Kim JY; Yoo C
    Skeletal Radiol; 2016 Feb; 45(2):235-42. PubMed ID: 26603891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of siderotic nodules in the liver with susceptibility weighted imaging: correlations to serum ferritin, Child-Pugh grade and hyaluronic acid levels.
    Tao R; You ZL; Zhang JQ; Dai YM; Zhou DQ; Cai P; Fan Y; Cui JG; Wang J
    Chin Med J (Engl); 2012 Sep; 125(17):3110-4. PubMed ID: 22932190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors.
    Mattison GR; Glazer GM; Quint LE; Francis IR; Bree RL; Ensminger WD
    AJR Am J Roentgenol; 1987 Apr; 148(4):711-5. PubMed ID: 3030082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 18. Kupffer cell function of hepatocellular adenoma: pulse sequence effects in superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Akatsu T; Ueda M; Shimazu M; Wakabayashi G; Aiura K; Tanabe M; Kawachi S; Tanimoto A; Shinmoto H; Sakamoto M; Kitajima M
    J Gastroenterol Hepatol; 2004 Aug; 19(8):951-2. PubMed ID: 15242510
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatocellular adenoma: MR imaging features with pathologic correlation.
    Chung KY; Mayo-Smith WW; Saini S; Rahmouni A; Golli M; Mathieu D
    AJR Am J Roentgenol; 1995 Aug; 165(2):303-8. PubMed ID: 7618545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic angiomyolipoma simulating hepatocytic tumor. 3 cases].
    Arblade S; Vilgrain V; Terris B; Zins M; Vullierme MP; Fléjou JF; Belghiti J; Menu Y
    Gastroenterol Clin Biol; 1996; 20(11):1022-6. PubMed ID: 9119173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.